Michael Heltzen's most recent trade in eXoZymes Inc. was a trade of 1,040 Common Stock done at an average price of $10.2 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eXoZymes Inc | Michael Heltzen | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.22 per share. | 02 Jul 2025 | 1,040 | 10,628 | - | 10.2 | 10,629 | Common Stock |
| eXoZymes Inc | Michael Heltzen | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 235,817 | 235,817 | - | - | Stock Options for Common Stock | |
| eXoZymes Inc | Michael Heltzen | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.78 per share. | 16 Jan 2025 | 1,767 | 3,872 | - | 10.8 | 19,048 | Common Stock |
| eXoZymes Inc | Michael Heltzen | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.72 per share. | 16 Jan 2025 | 121 | 2,105 | - | 10.7 | 1,297 | Common Stock |
| eXoZymes Inc | Michael Heltzen | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.10 per share. | 15 Nov 2024 | 1,984 | 1,984 | - | 11.1 | 22,022 | Common Stock |